Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

53 results about "Indolepropionic acid" patented technology

Bifidobacterium animalis subsp. Lactis B7 as well as composition and application thereof

The invention relates to a bifidobacterium animalis subsp. Lactis B7 as well as a composition and application thereof, and belongs to the technical field of microorganisms, the bifidobacterium animalis subsp. Lactis B7 is preserved in the China Center for Type Culture Collection on April 19, 2024, and the preservation number is CCTCC NO: M2024734. The bifidobacterium animalis subsp. Lactis B7 is named as Bifidobacterium animalis subsp. Lactis B7, the composition is named as Bifidobacterium animalis subsp. Lactis B7, and the composition is named as Bifidobacterium animalis subsp. Lactis B7. The invention also discloses application of the B7 fermentation composition in preparation of medicines for preventing and treating ulcerative colitis, constipation and constipation-type ulcerative colitis. According to the bifidobacterium animalis subsp. Lactis B7, high-yield short-chain fatty acid and indolepropionic acid are achieved, sulforaphane is generated through glucoraphanin, intestinal tract movement is improved, ulcerative colitis or inflammatory bowel disease activity index DAI and weight loss caused by the disease activity index DAI are effectively relieved, mouse colon injury is remarkably relieved, and mucosa layers are protected; the effects of resisting inflammation, inhibiting pathogenic bacteria and improving the intestinal barrier function are achieved.
Owner:SICHUAN GAOFUJI BIOLOGICAL TECH

Common bacteroides and application thereof

The invention provides common bacteroides and application thereof. Specifically, a strain of common bacteroides capable of producing 3-indolepropionic acid is separated from human feces for the first time, and the strain of common bacteroides is preserved in the China General Microbiological Culture Collection Center (CGMCC) on April 25, 2025, and the preservation number is CGMCC NO.46398. The strain of common bacteroides can be used for producing 3-indolepropionic acid, and the strain of common bacteroides can be used for producing 3-indolepropionic acid. Furthermore, the invention provides an application of the common bacteroides disclosed by the invention in production of 3-indolepropionic acid. Furthermore, the invention provides a method for producing the 3-indolepropionic acid by using the common bacteroides disclosed by the invention, and an application of the common bacteroides disclosed by the invention in increasing the content of the 3-indolepropionic acid in an organism.
Owner:ZHEJIANG UNIV

Method for simultaneously detecting residual quantity of 19 plant growth regulators in traditional Chinese medicinal materials

The invention discloses a method for simultaneously detecting residual quantity of 19 plant growth regulators in traditional Chinese medicinal materials, and belongs to the technical field of traditional Chinese medicinal material detection. The 19 plant growth regulators in the detected traditional Chinese medicinal materials are gibberellins, 4-chlorophenoxyacetic acid, 6-benzyladenine, paclobutrazol, 3-indolebutyric acid, thidiazuron, 2, 4-dihydroxyacetophenone and 2, 4-dihydroxyacetophenone respectively. The pesticide is prepared from the following raw materials: sodium 4-dichlorphenoxyacetate, forchlorfenuron, 3-indoleacetic acid, 4-fluorophenoxyacetic acid, isopentenyl adenine, imazalil, N-N '-diphenylurea, mepiquat chloride, diethyl aminoethyl hexanoate, 1-naphthylacetic acid amine, brassin, abscisic acid and 3-indolepropionic acid. According to the method, the QUECHERS traditional Chinese medicinal material sample on-machine pretreatment technology is applied, the ultra-high performance liquid chromatography-tandem mass spectrometry is established to measure the residual quantity of the 19 plant growth regulators in the medicinal materials, and the detection method is simple, clear, few in operation steps, extremely easy to operate, good in linear relation, good in sensitivity and high in accuracy.
Owner:玉林市食品药品检验检测中心(玉林市药品不良反应监测中心)

Application of indolepropionic acid in treatment of clostridium difficile infection

The invention discloses application of indolepropionic acid in treatment of clostridium difficile infection, and relates to the technical field of medicines. The invention discloses application of indolepropionic acid in preparation of a medicine for treating clostridium difficile infectious diseases and complications thereof. Compared with other types of AhR agonists, such as indole-3-formaldehyde, 3-indolecarbinol, indole-3-pyruvic acid and indolepropionic acid, have better effects in treatment of clostridium difficile infection, and can more effectively reduce the cytotoxicity of clostridium difficile strains.
Owner:SHENZHEN HOSPITAL OF SOUTHERN MEDICAL UNIV

Application of indole-3-propionic acid as biomarker in early warning of cognitive impairment after stroke

The invention discloses an application of indole-3-propionic acid as a biomarker in early warning of cognitive impairment after stroke. According to the application disclosed by the invention, the indole-3-propionic acid is confirmed as the biomarker of cognitive impairment after stroke through large-scale screening, and the indole-3-propionic acid belongs to a biomarker of a metabolite type, so that noninvasive sampling is facilitated, content fluctuation in a body can appear in a short time after stroke, and the cognitive impairment can be identified. The risk degree of cognitive impairment can be obtained by detecting within three months after stroke, the time node is earlier than that of conventional clinical diagnosis, and timely discovery and treatment are facilitated.
Owner:ZHUJIANG HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY

Application of indolepropionic acid in preparation of medicine for preventing or treating ovarian cancer

The invention discloses an application of indolepropionic acid in preparation of a medicine for preventing or treating ovarian cancer, the medicine takes indolepropionic acid as an active ingredient, the concentration is 0.1-1000 mu M, and the dosage forms comprise tablets, capsules, granules, pills, gels, suppositories, ointments, emulsions, mixtures, suspensions, injections and solutions. Administration routes comprise oral administration, injection administration, respiratory tract inhalation administration, local administration, sublingual administration and rectal administration, and can be combined with chemotherapeutic drugs for use. It is found through experiments that IPA with different concentrations can inhibit cell growth of ovarian cancer cell lines SKOV3 and A2780, cell proliferation of macrophages RAW264.7 is remarkably promoted, and the IPA has a potential immune promotion effect and good biological safety. In addition, the IPA can enhance the sensitivity of chemotherapeutic drugs, and the IPA and the chemotherapeutic drugs are combined to be applied to treatment of ovarian cancer, so that the treatment effect of the drugs can be remarkably improved.
Owner:SHANGHAI SHUIDA TECHNOLOGY TRANSFER CO LTD

Use and composition of postbiotic of lactobacillus paracasei et-22

The use and composition of a postbiotic of Lactobacillus paracasei ET-22, and the use of a lysate derived from Lactobacillus paracasei ET-22 in freshening breath and / or alleviating or inhibiting halitosis. The lysate is derived from heat-inactivated bacterial cells of Lactobacillus paracasei ET-22, the lysate at least comprises 2-hydroxy-3-phenylpropionic acid, NAD and a polypeptide, and the polypeptide has a structure as represented by formula 1. The postbiotic of and the lysate derived from Lactobacillus paracasei ET-22 can significantly reduce the contents of breath volatile sulfur compounds (VSCs) and salivary volatile organic compounds (VOCs) in the oral cavity, reduce the contents of characteristic flavor compounds, such as indoles, propionic acid and hexanoic acid, and can alter the oral microflora and inhibit the growth of oral biofilms and pathogenic bacteria, thus having the effects of freshening breath and alleviating or inhibiting halitosis.
Owner:INNER MONGOLIA YILI IND GROUP CO LTD

Application of indole-3-propionic acid in preparation of medicine for preventing and treating pulmonary ischemia reperfusion injury

The invention relates to application of indole-3-propionic acid in preparation of drugs for preventing and treating pulmonary ischemia reperfusion injury. Through in-vivo animals, the inventor finds that indole-3-propionic acid can reduce the lung injury score in a concentration-dependent manner, reduce the wet weight / dry weight ratio of lungs, relieve active oxygen accumulation after lung ischemia reperfusion, and reduce the levels of total protein, tumor necrosis factor alpha and interleukin 6 in alveolar lavage fluid; the cell level also shows that the indole-3-propionic acid can improve the vitality of alveolar epithelial cells after ischemia / reperfusion injury simulation in a concentration-dependent manner, reduce release of inflammatory factors such as tumor necrosis factors alpha, interleukin 6 and interleukin 1beta, and reduce accumulation of active oxygen in the cells. Results of integrating in-vitro cells and in-vivo animals show that the indole-3-propionic acid has the effect of preventing and treating the pulmonary ischemia reperfusion injury and has a good clinical application prospect.
Owner:THE PEOPLES HOSPITAL SHAANXI PROV

Application of 3-indolepropionic acid in improving reproductive performance of sows

The invention relates to the technical field of feed additives, in particular to application of 3-indolepropionic acid to improvement of reproductive performance of sows. The 3-indolepropionic acid is added into the feed for the sows in the middle and later periods of pregnancy, is used for improving the reproductive performance of the sows, and has a remarkable effect, so that the use amount of antibiotics for health care can be reduced in the breeding process of the sows. The feed additive prepared from the 3-indolepropionic acid can improve the average litter live piglet weight and average litter healthy piglet number of the sows, improve the lactation ability of the sows and relieve the postpartum lochia condition of the sows.
Owner:HUAZHONG AGRI UNIV

Bifidobacterium animalis lactis strain b7, composition and application thereof

This paper discusses a strain of Bifidobacterium animalis subsp. lactis B7 and its composition and applications, belonging to the field of microbial technology. The specific strain is Bifidobacterium animalis subsp. lactis B7. Bifidobacterium animalis subsp. lactis Bifidobacterium lactis subspecies B7 was deposited at the China Center for Type Culture Collection on April 19, 2024, with accession number CCTCC NO: M2024734. This invention also discloses the application of the B7 fermentation composition in the preparation of drugs for the prevention and treatment of ulcerative colitis, constipation, and constipation-predominant ulcerative colitis. This animal bifidobacterium lactis subspecies B7 produces high levels of short-chain fatty acids and indolepropionic acid, utilizes sulforaphane to generate sulforaphane, increases intestinal peristalsis, effectively alleviates the disease activity index (DAI) and weight loss caused by ulcerative colitis or inflammatory bowel disease, significantly reduces colonic damage in mice, protects the mucosal layer, has anti-inflammatory effects, inhibits pathogens, and improves intestinal barrier function.
Owner:SICHUAN GAOFUJI BIOLOGICAL TECH

Intestinal flora derivative indolepropionic acid capable of relieving obesity and application thereof

The invention relates to an intestinal flora derivative indolepropionic acid capable of relieving obesity and application thereof, and discloses new application of indolepropionic acid in obesity treatment. Indolepropionic acid is prepared through a microbial fermentation method, the purity is higher than that of indolepropionic acid prepared through a chemical synthesis method, multi-target metabolism regulation is achieved by activating a PPAR-gamma signal channel, and the effects of fat metabolism remodeling, liver injury repairing, glycometabolism regulation, inflammation inhibition and the like are achieved; compared with the prior art, the probiotic strain dependence is broken through, a single and definite active component, namely indolepropionic acid, is provided, and the complexity and effect fluctuation of flora intervention are eliminated; the multi-target metabolism regulation is realized, the increase of white fat browning and the reduction of liver fat decomposition are synchronously promoted, and the problem that the fat type cannot be converted by the existing metabolite is solved; the industrial feasibility is optimized, the high-purity indolepropionic acid is prepared through microbial fermentation, the cost is reduced compared with that of a chemical synthesis method, and the purity and production cost bottlenecks are broken through.
Owner:ZIGONG NO 4 PEOPLES HOSPITAL

Genetically engineered bacterium for synthesizing melatonin and application of genetically engineered bacterium

The invention relates to the field of genetic engineering and fermentation engineering, and discloses a genetically engineered bacterium for producing melatonin and application of the genetically engineered bacterium in fermentation production of melatonin. According to the invention, genes of mtrA, PTPS, SPR, PCD and DHPR of related enzymes synthesized by coding 2-amino-6-(1, 2-dihydroxypropyl)-5, 6, 7, 8-tetrahydro-4 (1H)-pterin diketone and genes of L-2-amino-3 (beta-indole) propionic acid monooxygenase, oxymethyltransferase, N-acetyltransferase and decarboxylase are co-expressed on the genetically engineered bacterium, so that the gene engineering bacterium is obtained. The strain can be used for fermentation production of melatonin, and experiments show that the yield of the strain can reach 6480 mg / L.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Application of indole-3-propionic acid in preparation of medicine for preventing or treating hematogenous infection

ActiveCN119679788AAntibacterial agentsOrganic active ingredientsPropanoic acidAnti-infective therapy
The invention discloses application of indole-3-propionic acid in preparation of a medicine for preventing or treating hematogenous infection, and belongs to the technical field of biological medicine. The invention discloses the application of indole-3-propionic acid in resisting blood-borne infection for the first time, the capability of capturing blood-borne pathogenic bacteria by liver Kupu cells can be remarkably enhanced by giving indole-3-propionic acid, and the load of pathogenic bacteria in circulating blood is reduced. The invention provides a new thought for treatment of hematogenous infection, especially anti-infection treatment of susceptible people with severe hepatitis or liver cirrhosis and the like. Indole-3-propionic acid is low in price and easy to obtain, can be produced in a large scale, is favorable for being developed into a medicine for treating hematogenous infection, and has a good application value.
Owner:ZHEJIANG UNIV

Application of metabolite in sow vaginal secretion in early pregnancy diagnosis

The invention provides an application of metabolites in sow vaginal secretion in early pregnancy diagnosis, and finds that three metabolic molecules can be used as markers for the early pregnancy diagnosis of sows for the first time on the basis of non-targeted metabonomics and machine learning conjoint analysis. According to the present invention, the metabolic markers are respectively INDOLEPROPIONIC ACID (indolepropionic acid), cis-Amonitate (cis-Amonitate) and 4-p-Coumaroylquinic acid (4-p-coumaroylquinic acid), the ROC curve AUC values of the metabolic markers are respectively 0.88, 0.92 and 0.77, and the metabolic markers have excellent diagnosis performance during the combination diagnosis. The pregnancy diagnosis is carried out by adopting the vaginal secretions of the sows 18 days after hybridization, the effective pregnancy diagnosis time is advanced by 5-8 days on the basis of a wave diagnosis method, and the method has important significance for reducing cost and increasing ultrasonic efficiency in live pig feeding.
Owner:SHIHEZI UNIVERSITY +3

pH-responsive double-network gel microspheres and their preparation method and application

The present invention discloses a double-network gel microsphere with pH response and its preparation method and application. The preparation method comprises: reacting indolepropionic acid with 2-hydroxyethyl vinyl ether under the catalytic action of EDC and NHS to prepare indolepropionic acid-2-hydroxyethyl vinyl ether polymer; reacting the indolepropionic acid-2-hydroxyethyl vinyl ether polymer with high-amylose starch under the catalytic action of p-toluenesulfonamide to prepare indolepropionic acid grafted starch; and mixing the indolepropionic acid grafted starch, sodium alginate and water as a dispersed phase; making a solution containing at least a surfactant as a continuous phase, and then using microfluidic technology to prepare double-network gel microspheres with pH response. The double-network gel microspheres with pH response prepared by the present invention have good thermal stability and pH responsiveness, and can achieve the processing of indolepropionic acid and polyphenols and the stability of oral delivery.
Owner:HEFEI UNIV OF TECH

Injectable hydrogel as well as preparation method and application thereof in neural restoration

The invention discloses injectable hydrogel and a preparation method and application thereof in nerve repair, the hydrogel is medical hydrogel of poly-beta amino ester loaded with indole-3-propionic acid, and the hydrogel comprises the following raw materials: polyethylene glycol diacrylate (PEGDA) as a scaffold material; a molecule containing a double primary amine group as a cross-linking agent, the cross-linking agent being cross-linked with polyethylene glycol diacrylate (PEGDA) via an acrylate bond; and indole-3-propionic acid (IPA) as an active ingredient. The injectable hydrogel is adjustable in mechanical property and excellent in biocompatibility, can slowly release IPA, and is used for filling nerve injury areas, inhibiting oxidative stress and promoting neuron regeneration and functional recovery.
Owner:NANTONG UNIV

Application of indole-3-propionic acid in preparation of medicine for treating myocardial ischemia-reperfusion injury

PendingCN121102206AOrganic active ingredientsCardiovascular disorderLeft ventricular sizeVentricular Ejection Fraction
The invention belongs to the technical field of medicines, and particularly relates to application of indole-3-propionic acid in preparation of a medicine for treating myocardial ischemia-reperfusion injury. A stable and reliable mouse MIRI model is successfully constructed through a coronary artery ligation left anterior descending branch reperfusion method, and it is found through indole-3-propionic acid (IPA) intervention and multi-dimensional evaluation that IPA administration can significantly improve the left ventricular ejection fraction LVEF and the left ventricular short-axis shortening rate LVFS of a model mouse, reduce the left ventricular end diastolic inner diameter LVEDd and the end systolic inner diameter LVESd, and significantly improve the model mouse left ventricular ejection fraction LVEF, the left ventricular end diastolic inner diameter LVEDd and the left ventricular end diastolic inner diameter LVESd. The heart function is effectively improved; the myocardial fibrosis area can be reduced, the mRNA expression of fibrosis-promoting and pathological hypertrophy-promoting molecules in myocardial tissues can be obviously reduced, and the myocardial injury progress can be inhibited in a multi-dimensional manner. The invention provides a brand new strategy for treating myocardial ischemia reperfusion injury, has important application value and wide clinical transformation prospect, and is expected to provide a new direction for clinical treatment.
Owner:NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV

Food for improving intestinal environment

The purpose of the present invention is to provide a food capable of increasing the production amount of indole-3-propionic acid produced by intestinal bacteria. This food for improving intestinal environment is obtained by combining (1) a digestion-resistant polysaccharide or a composition containing a digestion-resistant polysaccharide, and (2) a digestion-resistant protein or a composition containing a digestion-resistant protein. The food for improving intestinal environment contains at least one selected from the group consisting of enteric compositions that contain tryptophan or a salt thereof, digestion-resistant proteins that include tryptophan as a constituent amino acid, and compositions that contain a digestion-resistant protein including tryptophan as a constituent amino acid.
Owner:AJINOMOTO CO INC

Feed additive for improving pathogen resistance and intestinal injury of high-fat fed fish and application of feed additive

The invention discloses a feed additive for improving pathogen resistance and intestinal injury of high-fat fed fishes and application of the feed additive, and belongs to the technical field of fish feed. The feed additive is indole-3-propionic acid, and the application of the feed additive is that IPA is added into a high-fat feed according to the addition amount of 20-160 mg / kg. Experiments find that IPA with different concentrations can significantly improve the aeromonas hydrophila infection resistance of tilapia fed with high fat, enhance the intestinal immune enzyme activity, improve the intestinal permeability, enhance the intestinal antioxidant ability and relieve intestinal inflammation. The IPA disclosed by the invention can be used as a novel feed additive, can effectively relieve the problems of pathogen resistance reduction and intestinal injury of high-fat fed fishes, and has a good application prospect.
Owner:SHENZHEN AGRI UNIV FRONTIER TECH RES INST

Bacterial microenvironment-responsive immunomodulatory antimicrobial peptides and their preparation method and application

The present invention provides a kind of bacterial microenvironment responsive immunomodulatory antimicrobial peptide and its preparation method and application, belong to the field of bioengineering, its sequence is shown in SEQ ID No.1, its N-terminus is connected to the carboxyl group of indole 3-propionic acid, and the phenylalanine in the sequence is D-phenylalanine. Also disclosed is the application of the antimicrobial peptide of the present invention in the preparation of a drug for treating infectious diseases caused by Escherichia coli. The antimicrobial peptide of the present invention does not have direct bactericidal activity under physiological conditions, has a good antibacterial effect (16 μM) on Escherichia coli under acidic conditions, and has a macrophage immune response, promotes the phagocytic ability of macrophages to bacterial clusters. Therefore, the antimicrobial peptide of the present invention has selective bactericidal function, can coordinate the innate immune system, can effectively reduce bacterial selective pressure, and solves the problem of drug resistance.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

A crystal form of indolepropionic acid-metformin salt, its preparation method and uses

The application discloses a crystal form of indolepropionic acid-metformin salt and a preparation method and application thereof, and belongs to the technical field of chemical medicines and crystal form processes. The X-ray powder diffraction pattern of the crystal form has characteristic diffraction peaks at 8.8°±0.2°, 12.7°±0.2°, 14.1°±0.2°, 17.2°±0.2°, 18.0°±0.2°, 18.5°±0.2° and 19.6°±0.2°. The crystal form of indolepropionic acid-metformin salt provided by the application has good stability, improved solubility and dissolution rate compared with indolepropionic acid, can solve the problem of low solubility of indolepropionic acid, and combines metformin and indolepropionic acid which have a blood sugar lowering effect, and is expected to promote the design of indolepropionic acid preparations and the application in the clinical aspect, can have a pharmacological synergistic effect in the treatment of diabetes, and has the potential to develop a drug for treating diabetes.
Owner:SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES

Fluoro-18 labeled indolylpropionic acids and methods for their preparation

The application discloses a fluorine-18 labeled indole propionic acid and a preparation method thereof, and takes 1-(2-p-toluenesulfonic acid oxyethyl)-indole propionic acid methyl ester as a precursor, which is subjected to fluorination reaction with 18 F - to obtain an intermediate 1-[ 18 F] fluorinated ethyl-indole propionic acid methyl ester. The intermediate is hydrolyzed by NaOH to obtain a target compound 1-[ 18 F] fluorinated ethyl-indole propionic acid. The compound has good chemical stability, simple preparation, good biological performance, high chemical purity, and can be used as a new PET / CT positive electron tumor imaging agent for development and popularization and application.
Owner:THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV

Application of 3-indolepropionic acid in preparation of medicine for inhibiting generation of virulence factor of pseudomonas aeruginosa

The invention discloses an application of 3-indolepropionic acid in preparation of a medicine for inhibiting generation of a virulence factor of pseudomonas aeruginosa. According to the 3-indolepropionic acid, quorum sensing of pseudomonas aeruginosa and generation of related virulence factors of the pseudomonas aeruginosa are inhibited, so that in-vivo and in-vitro infection of the pseudomonas aeruginosa is inhibited, the death rate of a host is reduced, and a new treatment strategy is provided for prevention and control of infection of the pseudomonas aeruginosa.
Owner:SHENZHEN UNIV

Chocolate replicas made from individual components

ActiveDE202022003145U1CocoaPropanoic acidOctanoic Acids
Chocolate replica, comprehensive: a solid, plant-based substrate, mindestens 5 flüchtige organische Verbindungen (Volatile Organic Compounds, VOCs) ausgewählt aus 2,3-Diethylpyrazin, 2,3-Pentadion, 2-Methoxypyrazin, 5-Methyl-2-hepten-4-on, Acetoin, Kaffee-Furanon, Furfurylmercaptan, Indol, Propionsäure, Pyrazin, Valeriansäure, Vanillinpropylenglykolacetal, Vanillylethylether, 1-Heptanol, 2,3,5-Trimethyl-6-ethylpyrazin, 2,3-Butandion, 2,4,5-Trimethylthiazol, 2-Acetylpyridin, 2-Ethoxy-3-methylpyrazin, 2-Ethyl-1-hexanol, 2-Ethyl-6-methylpyrazin, 2-Isobutyl-3-methoxypyrazin, 2-Isopropyl-5-methyl-2-hexenal, 2-Methylbutyraldehyd, 2-Methylfuran, 2-Methyl-1-butanol, 2-Octanol, 2-Octanon, 2-Pentanol, 2-Phenyl-2-butenal, 2-Phenylpropionaldehyd, 3,4-Hexandion, 3,5-Diethyl-2-methylpyrazin, 3-Octanon, 4,5-Dimethyl-2-ethyl-3-thiazolin, 4-Ethylguaiacol, 4-Hydroxy-2,5-dimethyl-3(2H)-furanon, 4-Methyl-2-phenyl-2-pentenal, 4'-Methylacetophenon, 5-Methylfurfural, Amylacetat, Benzylalkohol, beta-Damascenon, Damascenon, delta-Decalacton, delta-Octalacton,Ethyl-2-methylbutyrat, Ethyl-3-phenylpropionat, Ethylacetat, Ethylbutanoat, Ethylisobutyrat, Ethylisovalerat, Eugenol, Furfurylacetat, Furfurylpropionat, Geraniol, Hexylisobutyrat, Isoamylbenzoat, Isoamylbutyrat, Isoamylphenylacetat, Isopropenylpyrazin, Linalooloxid, Methional, Methyl-2-thiofuroat, Methylbutyrat, Methyl-p-anisat, Methylphenylacetat, Octanal, p-Kresol, Phenol, Phenylessigsäure, Prenylbenzoat, Propanol, Propenal, Propyl-2-furoat, Pyridin, Syringol, Tetrahydrofurfurylphenylacetat, trans-2-Nonenal und Tricyclodecenylisobutyrat, und , at least 5 non-volatile compounds selected from choline, pyridine, pyridoxine, 2(5H)-furanone, 2,3-dimethylpyrazine, caffeine, orientin, 4-hydroxybenzaldehyde, methyl 2-pyrrolyl ketone, 2,3,5-trimethylpyrazine, 2,3,5,6-tetramethylpyrazine, isoprenylpyrazine, 2-isopropyl-3-methoxypyrazine, piperine, 2-isobutyl-3-methoxypyrazine, catechin, adipic acid, methyl gallate, epicatechin, rutin, trans-ferulic acid, sinapic acid, resveratrol, ellagic acid, propyl gallate, salicylic acid, quercetin, hesperetin, AMP, hydroxymethylfurfural, procyanidin B1, pantothenic acid, sotolon, caffeic acid, epicatechin gallate, vanillic acid, syringic acid Homofuraneol, vanillin, syringaldehyde, coumaric acid, acetovanillone, cinnamic acid, luteolin, polydatin, cytosine, CMP, adenine, cytidine, guanine, 4-guanidinobutyric acid, uracil, tyramine, tryptamine, maltol, maple furanone, acetanilide, sorbic acid, phenylalanine, leucine, glucosamine, methionine, GABA, Tyrosine, Lysine, Histidine, Glycine, Serine, Aspartic Acid, Isoleucine, Tryptophan, Valine, Proline,Carnitine, Arginine, Ornithine, β-Alanine-2, Threonine, Glutamine, Asparagine, Cysteine, Glutamic acid, Betaine, Pipecolic acid, trans-4-Hydroxyproline, Citrulline, Carnosine, Homoserine, Cystine, Kynurenic acid, Ribose, Arabitol, Fructose, Rhamnose, Mannitol, Glucose, Lactose, Xylose, Sorbitol, Fucose, Galactose, Mannose, Sucrose, Myo-Inositol, D-Glucuronic acid, Quinic acid, Malic acid, Pyruvic acid, Tartaric acid, Lactic acid, Citric acid, Fumaric acid, Succinic acid, Gallic acid, Furan-2-carboxylic acid, 3,4-Dihydroxybenzoic acid, 2-Isopropyl malic acid, D-Gluconic acid, 4-Methoxycinnamic acid, 2-Ethyl-2-hydroxybutyric acid, Ricinoleic acid DL-Hydroxystearic acid, nicotinic acid, 8-hydroxyquinoline, quinoline, 5-methoxyresorcinol, chlorogenic acid, ethyl nicotinate and eugenyl acetate, wherein the chocolate replica has the taste and aroma of a traditionally produced chocolate and wherein the traditionally produced chocolate is produced according to a standard chocolate-making process.
Owner:VOYAGE FOODS INC OAKLAND

Application of indolepropionic acid in preparation of product for preventing and treating alcoholic liver injury

The invention provides application of indolepropionic acid (IPA) in preparation of a product for preventing and treating alcoholic liver injury, and relates to the technical field of medicines. The invention discloses indolepropionic acid or starch ester indolepropionylated high amylose corn starch (HAMSIPA) for the first time, which can be used for remarkably relieving alcoholic liver injury, improving liver functions, liver fatty degeneration and liver oxidative stress of individuals with alcoholic liver injury, protecting intestinal barrier injury of the individuals with alcoholic liver injury, and improving the intestinal barrier injury of the individuals with alcoholic liver injury. And intestinal lipopolysaccharide (LPS) is prevented from leaking out and entering the hepatic portal vein, so that the activation of a liver inflammatory pathway is inhibited, and finally, the intestinal liver axis homeostasis is maintained. The indolepropionic acid has a wide application prospect in the aspect of alcoholic liver injury, and the application scene of indolepropionic acid is widened.
Owner:QILU UNIVERSITY OF TECHNOLOGY (SHANDONG ACADEMY OF SCIENCES)

Application of indolepropionic acid in preparation of medicine for treating depression

The invention discloses application of indolepropionic acid or pharmaceutical salt thereof in preparation of a medicine for preventing and / or treating depression. The indole-3-propionic acid provided by the invention is used as an auxiliary medicine for treating depression, and the indole-3-propionic acid can relieve depression-like behaviors of depression mice and improve hippocampal neuron damage of the depression mice, so that the indole-3-propionic acid can be used as a medicine for treating depression.
Owner:THE NAVAL MEDICAL UNIV OF PLA

Feed additive for improving fish fatty liver disease and application thereof

The invention discloses a feed additive for improving fish fatty liver diseases and application of the feed additive, and belongs to the technical field of fish feed. The invention provides a feed additive taking indole-3-propionic acid (IPA) as an active ingredient. The feed additive is added into a high-fat feed at the concentration of 20-160 mg / kg. Experimental results show that the additive can significantly reduce the size of liver lipid droplets of high-fat fed tilapia, reduce the content of liver triglyceride, total cholesterol and free fatty acid, and relieve liver oxidative stress and liver injury. The invention provides a novel feed additive scheme for relieving fish fatty liver diseases.
Owner:SHENZHEN AGRI UNIV FRONTIER TECH RES INST

Preparation method and application of deep-grain walnut inner seed coat extract

The invention discloses a preparation method of a deep-grain walnut inner seed coat extract, which specifically comprises the following steps: adding crushed deep-grain walnut inner seed coats and distilled water into a high-pressure reaction kettle, stirring and extracting for 10-20 minutes at 100-120 DEG C and 1-3 MPa, collecting an extracting solution, and carrying out rotary evaporation concentration and freeze drying to obtain a crude extract; dissolving the crude extract with water, adjusting the pH value to 2-3, purifying the crude extract solution with NKA-9 type macroporous resin, eluting with an ethanol solution with the volume concentration of 45-65%, collecting the eluent, and concentrating and drying to obtain the deep-grain walnut inner seed coat extract. After the extract is subjected to in-vitro simulated digestion fermentation, the abundance of beneficial bacteria can be increased, generation of flora metabolites, namely short-chain fatty acid and indolepropionic acid is promoted, and polyphenol can be converted into urolithin which is easier to absorb and has better activity under the action of flora; the method disclosed by the invention expands the activity of the deep-grain walnut endopleura polyphenol, and provides a new way for preventing intestinal microbe disorder by using the deep-grain walnut endopleura polyphenol as prebiotics.
Owner:KUNMING UNIV OF SCI & TECH

Use of indole propionic acid in treatment of autoimmune liver injury and cirrhosis

The present invention relates to the use of indole propionic acid in liver disease. Specifically, the present application discloses the use of indole propionic acid or a pharmaceutically acceptable salt thereof or a derivative thereof in preparing a medicine or a pharmaceutical composition or a kit for preventing and / or treating cirrhosis and acute autoimmune liver disease caused by chronic liver injury.
Owner:SHANGHAI EAST HOSPITAL EAST HOSPITAL TONGJI UNIV SCHOOL OF MEDICINE

A method for the synthesis of a non-natural indole amino acid

This invention utilizes gene mining technology, random mutation, and other methods to... Schistosoma mansoni The indole monooxygenase source was modified to obtain a mutant with a high yield of DL-2-amino-3-(5-hydroxyindole)propionic acid. The recombinant vector constructed from the mutant and the recombinant genetically engineered bacteria were then used to produce DL-2-amino-3-(5-hydroxyindole)propionic acid via fermentation, resulting in a significantly increased yield, 1.5-5.2 times that of the starting strain. Therefore, this invention provides a method for producing DL-2-amino-3-(5-hydroxyindole)propionic acid that offers advantages such as mild reaction conditions, simple operation, short production cycle, environmental friendliness, and reduced production costs.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI